Active substance
Ranibizumab
10 products from 8 companies contain this in European Union.
10 prescription only
Prescription only
ByoovizEU authorisation Samsung Bioepis NL B.V. · Ranibizumab · S01LA04Epruvy (previously Ranibizumab Midas)EU authorisation Midas Pharma GmbH · Ranibizumab · S01LA04LucentisEU authorisation Novartis Europharm Limited · Ranibizumab · S01LA04RanivisioEU authorisation Midas Pharma GmbH · Ranibizumab · S01LA04RanluspecEU authorisation Lupin Europe GmbH · Ranibizumab · S01LA04RexatiluxEU authorisation Intas Third Party Sales 2005 S.L. · Ranibizumab · S01LA04RimmyrahEU authorisation Qilu Pharma Spain S.L. · Ranibizumab · S01LA04SusvimoEU authorisation Roche Registration GmbH · Ranibizumab · S01LA04VislyfaEU authorisation Lupin Europe GmbH · Ranibizumab · S01LA04XimluciEU authorisation STADA Arzneimittel AG · Ranibizumab · S01LA04
Same substance is not the same product. Strength, form, release mechanism and other ingredients all differ. Whether one can replace another is a decision for a pharmacist.